오픈뉴스백과
둘러보기ONP 브리핑뉴스
회사학술과학정부용어사전커뮤니티피드 제보
...

오픈뉴스백과

집단지성 기반 뉴스 검증 플랫폼. 다양한 시각으로 뉴스를 이해합니다.

서비스

세계의 오늘한국의 오늘뉴스정부과학학술용어사전소개

법적 고지

개인정보처리방침이용약관콘텐츠 이용 안내

문의

이메일 문의

본 플랫폼에서 제공하는 뉴스 콘텐츠의 저작권은 각 언론사에 있으며, 무단 복제 및 배포를 금지합니다.

RSS 피드를 통해 수집된 콘텐츠는 각 원저작자의 라이선스 조건을 따릅니다. 오픈 라이선스(CC-BY 등) 콘텐츠는 해당 라이선스에 따라 출처를 표기합니다.

오픈뉴스백과는 뉴스 집계 및 검증 플랫폼으로, 개별 기사의 내용에 대한 책임은 해당 언론사에 있습니다.

이용자가 작성한 피드백, 팩트체크, 독자 제보 등의 콘텐츠에 대한 책임은 해당 작성자에게 있습니다.

콘텐츠 제거 요청: contact@opennewspedia.com

© 2026 오픈뉴스백과 (OpenNewsPedia). All rights reserved.

뉴스 목록
미디어 커버리지1건1개 미디어
보수 성향 100%
The Economic Times (India)
경제
보수 성향

NITI Aayog proposes pharma chapter for FTAs

The Economic Times (India)
조회 0

이 뉴스, 어떠셨어요?

한 번의 탭으로 반응을 남겨요 · 로그인 불필요

New Delhi: Niti Aayog has proposed a model chapter on the pharmaceutical sector to serve as a blueprint for future free trade agreements to improve regulatory predictability, while urging India to diversify into high-value pharmaceutical segments.In the eighth edition of Trade Watch Quarterly, the Aayog backed greater regulatory transparency and stronger industry-academia technology transfer in life sciences clusters to accelerate patent commercialisation, research collaboration and startup incubation.The report also called for environmental compliance to be shifted from individual firms to shared infrastructure, saying stricter environmental requirements have significantly increased manufacturing and research and development costs.It noted that India's pharma supply chain remains heavily dependent on China for critical active pharmaceutical ingredients (APIs) and key starting materials, with 65% of such imports sourced from the country.

Weak innovation and commercialisation ecosystems, it said, have created uncertainty for innovators and long-term investment.

Niti Aayog VC Ashok Kumar Lahiri said India is widely regarded as the pharmacy of the world."Niti Aayog has found out that while we are doing all right in terms of volume in the pharmaceutical sector, we need to move up the value chain," Lahiri said.

India has built credibility in global markets and its pharmaceutical companies should be able to command a larger international presence if they offer high-quality, competitively priced branded products, he said."As global market dynamics rapidly shift towards high value, knowledge-intensive biopharmaceuticals, India must complement its traditional manufacturing scale with deeptech innovation... to graduate from the pharmacy of the world to an undisputed capital for pharma innovation," the report said.India supplies affordable generic medicines to markets around the world, meeting about 50% of Africa's, 40% of the US' and 25% of the UK's generic drug requirements. ...

전문 보기

관련 뉴스

관련 뉴스 제보는 로그인 후 가능합니다.

'economy' 카테고리 뉴스

Rakuten to offer satellite-to-cell service in Japan with US startup

Nikkei Asia

Alphabet added to Dow Jones Industrial Average, replacing Verizon

CNBC Top News

Alphabet’s stock is set to join the Dow. Here’s which company is getting the boot.

MarketWatch

The Economic Times의 다른 기사

US Stock: S&P, Nasdaq end lower on semiconductor selloff as AI spending concerns mount

The Economic Times (India)

India to operationalise up to 60 mines in FY27

The Economic Times (India)

Govt races to protect kharif output amid 42% rain

The Economic Times (India)

피드백

피드백을 남기려면 로그인해 주세요.